Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Interest Coverage Ratio of 0.42 for Q2 2026, up 83.91% year-over-year from 0.23 in Q2 2025, and up 40.54% quarter-over-quarter from 0.7 in Q1 2026.
Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.42 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio rose 83.91% year-over-year to 0.42; the TTM figure through Jun 2026 stood at 1.59 (up 83.39% YoY), while the FY2025 annual figure was 1.42, up 0.96% from the prior year.
- Interest Coverage Ratio for Q2 2026 stood at 0.42, up from 0.7 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 335.66 in Q2 2023, with the low at 135.29 in Q4 2024.
- The 4-year median for Interest Coverage Ratio is 0.75 (2025), against an average of 25.84.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio surged 99.34% in 2024, then slumped 578.07% in 2025.
- Contineum Therapeutics' Interest Coverage Ratio stood at 166.83 in 2023, then tumbled by 181.1% to 135.29 in 2024, then soared by 85.17% to 20.06 in 2025, then soared by 97.92% to 0.42 in 2026.
- Business Quant data shows CTNM's Interest Coverage Ratio at 0.42 in Q2 2026, 0.7 in Q1 2026, and 20.06 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | -0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.42 |
| Mar 31, 2026 | -0.70 |
| Dec 31, 2025 | -20.06 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -6.16 |
| Mar 31, 2025 | -3.06 |
| Dec 31, 2024 | -135.29 |
| Mar 31, 2024 | -0.37 |
| Jun 30, 2023 | 335.66 |
| Mar 31, 2023 | -55.60 |